Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
PR Newswire

News of the day

Schofield Publishing Enters the Newsletter Market

4th September 2008 BOSTON, CHICAGO, LONDON, NEW YORK, NORWICH, England and ONGAR, Ireland, September 4 /PRNewswire/ -- Schofield Publishing, a division of Schofield Media Europe Ltd, announced on the 29th August that it has acquired Health and Safety Monitor publication from Silverdog Publishing. Health and Safety Monitor was launched at the same time as the iconic Health and Safety at Work Act 1974 and has tracked the developing legislation since then. It has been relied upon by blue-chip corporates,... more

After Their U.S. Purchase, Algorithme Pharma Gains a Foothold in Europe Through the Acquisition of a New Clinical Research Location in the United Kingdom

26th August 2008 LAVAL, Canada, August 26 /PRNewswire/ -- The Laval-based firm Algorithme Pharma is pleased to announce that it has achieved its goal of securing a European facility through its acquisition of Simbec Research Ltd in Merthyr Tydfil, Wales. This news comes only six weeks after confirming the purchase of another clinical research centre in Baltimore, Maryland. This important acquisition will enable Algorithme Pharma, a worldwide leader in clinical research and bioanalysis, to continue its... more

Hoya Vision Care Expands in Czech Republic

21st August 2008 UITHOORN, the Netherlands, August 21 /PRNewswire/ -- Hoya Corporation's Vision Care Division, a key player in the global market for ophthalmic lenses, announced today that it acquired Dioptra CZ a.s., one of the leading distributors of ophthalmic lenses in the Czech Republic. Dioptra has a long and rich tradition in the optical field, with origins dating back to 1896. Hoya and Dioptra have worked together under an exclusive arrangement since the year 2000. Dioptra CZ employs 32 people in... more
Acquisitions, Mergers and Takeovers RSS feed

PR Newswire search

Search the PR Newswire by keyword. Alternatively our advanced search allows you to query by category.
Category
To choose more then one item on the list hold CTRL button while selecting. To deselect items press CTRL button and deselect.

More recent news

Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document
13th August 2008 BASINGSTOKE, England and CAMBRIDGE, Massachusetts, August 13 /PRNewswire/ -- Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that since July...

Shire Announces Holding of 81% in Jerini AG and Publication of Offer Document
13th August 2008 BASINGSTOKE, England and CAMBRIDGE, Massachusetts, August 13 /PRNewswire/ -- Shire Limited (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that since July...

Global Med Technologies Announces Acquisition of eDonor(R): One of the Industry's Premier Technology Platforms for Donor Recruitment, Scheduling and Retention
1st August 2008 DENVER, August 1 /PRNewswire/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today...

ThromboGenics Announces Private Investors Acquire 8% Stake in the Company
30th July 2008 LEUVEN, Belgium, July 30 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), a biotechnology company focused on eye disease, vascular disease and cancer, today announces that a group of...

Rosetta Genomics Completes Acquisition of Parkway Clinical Laboratories Inc.
24th July 2008 REHOVOT, Israel and JERSEY CITY, New Jersey, July 24 /PRNewswire/ -- Rosetta Genomics Ltd. (Nasdaq: ROSG), a leader in the development of microRNA-based diagnostics and therapeutics, announced...

Roche Proposes to buy Full Stake in Genentech - Interview With Chairman
21st July 2008 LONDON, July 21 /PRNewswire/ -- Roche, the healthcare company, announced today that it has proposed to acquire the outstanding publicly held interest in biotech company Genentech for US$89.00 per...

SmoothToe Diabetic Socks Acquired by Lifestyle Medical Group
9th July 2008 SAINT CHARLES, Minnesota, July 9 /PRNewswire/ -- SmoothToe, the only brand of diabetic socks available anywhere in the world with a Lifetime Blister Free Guarantee as well as a Five Year...

Gen-Probe Does Not Intend to Increase Offer to Acquire Innogenetics
9th July 2008 SAN DIEGO, July 9 /PRNewswire/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company does not intend to increase the value of its conditional tender offer to acquire 100% of the...

t+ Medical Acquires Vivatec Ltd
9th July 2008 OXFORD, England, July 9 /PRNewswire/ -- t+ Medical is delighted to announce the acquisition of Vivatec Ltd. Following a period of rapid expansion including a successful launch of t+ Clinical into the...

Johnson & Johnson Nordic AB Acquires Amic
18th June 2008 SOLLENTUNA, Sweden, June 18 /PRNewswire/ -- Johnson & Johnson Nordic AB, a Johnson & Johnson company, today announced the acquisition of Amic, a privately held Swedish developer of in...

Essilor Agrees to Acquire Satisloh The World Leader in Optical Manufacturing Solutions
16th June 2008 CHARENTON-LE-PONT, France, June 16 /PRNewswire/ -- Essilor and the Swiss company Schweiter Technologies AG announced today that they have signed a share purchase agreement whereby Essilor will...

Gen-Probe Launches Cash Tender Offer to Acquire Belgian Molecular Diagnostics Company Innogenetics
3rd June 2008 SAN DIEGO, June 3 /PRNewswire/ -- Gen-Probe Incorporated (Nasdaq: GPRO), a pioneer and leader in nucleic acid diagnostics for human disease, announced today that it has launched a conditional tender...

Quintiles Signs Agreement to Acquire Eidetics
7th May 2008 RESEARCH TRIANGLE PARK, North Carolina, May 7 /PRNewswire/ -- Quintiles Transnational Corp. today announced that it has signed an agreement to acquire Eidetics, a privately held decision-analytics...

Stiefel Laboratories, Inc. Acquires ABR Invent and ABR Development
6th May 2008 CORAL GABLES, Florida, May 6 /PRNewswire/ -- Stiefel Laboratories, Inc., the world's largest independent pharmaceutical company specializing in dermatology, announced today that it has acquired ABR...

vision4health Acquires MOLIS From SYSMEX
1st May 2008 WILEN, Germany, May 1 /PRNewswire/ -- Effective immediately, vision4health has acquired the MOLIS laboratory information system division from the Japanese SYSMEX Group. The company, set up in 2007...

Agreement Executed for Amneal Pharmaceuticals to Acquire the Assets of Interpharm Holdings
25th April 2008 PATERSON, New Jersey, April 25 /PRNewswire/ -- Amneal Pharmaceuticals, LLC is pleased to announce the execution of an Asset Purchase Agreement for Amneal's wholly-owned subsidiary,...

Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
24th April 2008 BASINGSTOKE, England and CAMBRIDGE, Massachusetts, April 24 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces the acquisition of...

TopoTarget Successfully Buys Back Full Control of Belinostat
22nd April 2008 COPENHAGEN, April 22 /PRNewswire/ -- TopoTarget A/S (OMX: TOPO) today announced that the company has successfully gained full control of belinostat so that global rights are now wholly owned by the...

Excalibur Celebrates PIramed Sale With 'Substantial Cash Return' to Investors
15th April 2008 GLASGOW, Scotland, April 15 /PRNewswire/ -- Excalibur, the new international investment house launched by Sir Christopher Evans, today (Tuesday) welcomed the sale of PIramed to Roche. (Photo:...

Galderma Completes Acquisition of CollaGenex
11th April 2008 LAUSANNE, Switzerland, April 11 /PRNewswire/ -- Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, today announced that its U.S. holding company,...

Molecular Vision and Acrongenomics Unable to Reach Agreement on the Acquisition of Molecular Vision
8th April 2008 LONDON, April 8 /PRNewswire/ -- The Board of Molecular Vision today announces that discussions with Acrongenomics on the proposed acquisition of Molecular Vision have now ceased. Acrongenomics has...

Galderma Completes Tender Offer for CollaGenex
7th April 2008 LAUSANNE, Switzerland, April 7 /PRNewswire/ -- Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, today announced that its U.S. holding company,...

Essilor Strengthens its Positions in Italy - Three New Acquisitions in the United States
4th April 2008 CHARENTON-LE-PONT, France, April 4 /PRNewswire/ -- Essilor is pursuing its external growth strategy in Italy and the United States. The Group has stepped up its development in Italy with...

VWR International, LLC Acquires Jencons (Scientific) Ltd, UK
1st April 2008 WEST CHESTER, Pennsylvania, April 1 /PRNewswire/ -- VWR International, LLC, a leading global laboratory supply company, today announced that it has acquired Jencons (Scientific) Limited, a UK...

Global Med Technologies(R), Inc. Signs Purchase Agreement to Acquire Inlog, SA, a European Medical Software Firm
31st March 2008 DENVER, March 31 /PRNewswire/ -- Global Med Technologies(R), Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international e-Health, medical information technology company, today...

Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals
19th March 2008 LAUSANNE, Switzerland, March 19 /PRNewswire/ -- Galderma Pharma S.A., a global specialty pharmaceutical company focused on dermatology, today announced that its U.S. holding company,...

Hikma - 2007 Preliminary Results Interviews With CEO and CFO
18th March 2008 LONDON, March 18 /PRNewswire/ -- In video interviews Said Darwazah, CEO, and Bassam Kanaan, CFO, discuss Hikma's 2007 performance, financing and acquisitions, plus what they are expecting from the...

Genmab and PDL BioPharma Close Sale of Antibody Manufacturing Facility
14th March 2008 COPENHAGEN, Denmark and REDWOOD CITY, California, March 14 /PRNewswire/ -- - Summary: Genmab's Acquisition of PDL BioPharma's Antibody Manufacturing Facility has Closed.

EUSA Pharma to Acquire US Specialty Oncology Company Cytogen
11th March 2008 DOYLESTOWN, Pennsylvania and OXFORD, England, March 11 /PRNewswire/ -- - Acquisition of US Infrastructure Completes Build of EUSA's Transatlantic Commercialization Platform

Acrongenomics Acquires Equity Stake in Molecular Vision
4th February 2008 GENEVA, February 4 /PRNewswire/ -- Acrongenomics, Inc. (OTC: AGNM) is pleased to announce that they have acquired a 10.9% interest in Molecular Vision Limited, on a fully diluted basis. The cash...

2007 Another Record Year in Terms of Sales and Earnings for Gerresheimer
4th February 2008 DUSSELDORF, Germany, February 4 /PRNewswire/ -- According to provisional figures, Gerresheimer AG has just completed another record year. In 2007 the company achieved sales of EUR957.7m, up by 48.1%;...

2007 Another Record Year in Terms of Sales and Earnings for Gerresheimer
4th February 2008 DÜSSELDORF, Germany, February 4 /PRNewswire/ -- According to provisional figures, Gerresheimer AG has just completed another record year. In 2007 the company achieved sales of EUR957.7m, up by...

Chiltern Announced Today That it has Acquired the Business of Drug Development Solutions (DDS)
1st February 2008 LONDON, February 1 /PRNewswire/ -- Chiltern, the global contract research organization, announced today that it has acquired the business of Drug Development Solutions ('DDS'), a leading Phase 1 unit...

Partnering consultation free of charge
Bioiberica
Yissum Technology Transfer Hebrew University
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us